Trial document




drksid header

  DRKS00021578

Trial Description

start of 1:1-Block title

Title

Validation of new detection methods for SARS CoV-2 in suspected COVID-19

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

[---]*

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

The goal of this study is to validate new and possibly faster methods of detecting SARS CoV-2. Patients who receive a mucosal swab to test for SARS CoV-2 in the Klinikum Konstanz receive a second swab. This second swab is subsequently used to validate and improve new methods of detecting SARS CoV-2 i.e. by changing Temperature or pH. In the future these new methods of detecting SARS CoV-2 could be used to better understand the prevalence and transmission of the virus.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

The goal of this study is to validate new and possibly faster methods of detecting SARS CoV-2. Patients who receive a mucosal swab to test for SARS CoV-2 in the Klinikum Konstanz receive a second swab. This second swab is subsequently used to validate and improve new methods of detecting SARS CoV-2 i.e. by changing Temperature or pH. In the future these new methods of detecting SARS CoV-2 could be used to better understand the prevalence and transmission of the virus.

end of 1:1-Block scientific synopsis
start of 1:1-Block forwarded Data

Do you plan to share individual participant data with other researchers?

No

end of 1:1-Block forwarded Data
start of 1:1-Block forwarded Data Content

Description IPD sharing plan:

[---]*

end of 1:1-Block forwarded Data Content
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00021578
  •   2020/04/28
  •   [---]*
  •   yes
  •   Approved
  •   Eilentscheid 05/2020, Ethikkommission der Universität Konstanz
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  •   U0351-4483-4510 
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   SARS CoV-2
  •   U07.1 -  Emergency use of U07.1
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Naso-pharyngeal swab testing for SARS-CoV-2
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Non-interventional
  •   Other
  •   Single arm study
  •   Open (masking not used)
  •   [---]*
  •   Uncontrolled/Single arm
  •   Screening
  •   Single (group)
  •   I
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Validation of a new detection method for SARS CoV2

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

none

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2020/04/24
  •   300
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   18   Years
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

Medical indication to perform a mucosal swab for SARS CoV-2

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

none

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Universität KonstanzLehrstuhl Zellbiologie
    • Mr.  Prof. Dr.  Christof  Hauk 
    • Universitätsstraße 10
    • 78646  Konstanz
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Lehrstuhl ZellbiologieFachbereich BiologieUniversität Konstanz
    • Mr.  Professor  Christof  Hauck 
    • Universitätsstraße 10
    • 78646  Konstanz
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Medizinische Klinik I, Klinikum Konstanz
    • Mr.  Professor  Marcus  Schuchmann 
    • Mainaustraße 35
    • 78644  Konstanz
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Lehrstuhl ZellbiologieFachbereich BiologieUniversität Konstanz
    • Mr.  Professor  Christof  Hauck 
    • Universitätsstraße 10
    • 78646  Konstanz
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting ongoing
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.